Recent News

• 06.27.2025 - Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
• 06.27.2025 - Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
• 05.08.2025 - Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
• 05.08.2025 - Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
• 03.29.2025 - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
• 03.29.2025 - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.04.2025 - Turnstone Biologics Announces Plans to Explore Strategic Alternatives
• 02.04.2025 - Turnstone Biologics Announces Plans to Explore Strategic Alternatives
• 11.12.2024 - Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
• 11.12.2024 - Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

Recent Filings

• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.09.2025 - EX-99.1 EX-99.1
• 05.09.2025 - 8-K Current report
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.01.2025 - 8-K Current report
• 03.31.2025 - EX-99.1 EX-99.1
• 03.31.2025 - 8-K Current report
• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.04.2025 - 8-K Current report
• 02.04.2025 - EX-99.1 EX-99.1